The Discounted Cash Flow (DCF) valuation of Santhera Pharmaceuticals Holding AG (SANN.SW) is (359.83) CHF. With the latest stock price at 10.60 CHF, the upside of Santhera Pharmaceuticals Holding AG based on DCF is -3494.6%.
Based on the latest price of 10.60 CHF and our DCF valuation, Santhera Pharmaceuticals Holding AG (SANN.SW) is a sell. selling SANN.SW stocks now will result in a potential gain of 3494.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.5% | 6.5% |
| Long-term Growth Rate | 3.0% - 4.6% | 3.8% |
| Fair Price | (1,061.93) - (220.61) | (359.83) |
| Upside | -10118.2% - -2181.2% | -3494.6% |